Skovos guide

What is human-in-the-loop AI in healthcare?

Human-in-the-loop AI in healthcare is a design in which a qualified person reviews, approves, or can override an AI system's output before it affects a patient or a business decision. The human is a real control point with the information and authority to say no, not a formality added after the AI has already acted.

Levels of human involvement

Human oversight comes in degrees:

The right level depends on how close the task is to clinical decisions and how reversible a mistake would be.

Where the idea shows up in US rules

The FD&C Act excludes certain clinical decision support software from the medical device definition when, among other criteria, it enables a health care professional "to independently review the basis for such recommendations that such software presents so that it is not the intent that such health care professional rely primarily on any of such recommendations" (21 U.S.C. 360j(o)(1)(E)(iii)). In other words, whether a clinician can meaningfully check the AI's reasoning can affect how the software is regulated. FDA explains how it applies these criteria in its clinical decision support software guidance.

The Joint Commission and CHAI guidance on the Responsible Use of AI in Healthcare warns that "overreliance on AI could potentially diminish the role of human judgment in clinical decision-making," and encourages "a collaborative environment where human judgment and AI tools complement each other."

Making human review meaningful

A human checkpoint can fail quietly. Automation bias leads reviewers to accept AI output they would have questioned from a colleague, and high volumes lead to rubber-stamping. The OVERT runtime evidence specification addresses this for AI agents: TOOL-4 requires that "sensitive tool operations SHALL require explicit human approval with attested identity binding," and TOOL-4.4 sets a maximum approval velocity so approvals made too quickly are flagged for secondary review. HITL-3 requires that human corrections and overrides be attested.

Practical safeguards include showing reviewers the AI's inputs and rationale, not just its answer; tracking override and acceptance rates; limiting queue sizes; and recording who approved each action. Organizations should also decide in advance what happens when a reviewer is unavailable: whether the AI waits, escalates to someone else, or falls back to a manual process. Periodic audits that compare approved AI outputs with later outcomes show whether review is catching errors or simply passing them through.

How Skovos handles this

Skovos supports human oversight of AI agents rather than replacing it. Agents act only within scopes that people approved, every permission decision and recorded action lands in the hash-chained audit trail for human review, and a person at the hospital can recall an agent at any time.

Frequently asked questions

Is human-in-the-loop required for clinical AI?

No single US rule requires it for all clinical AI. But whether a clinician can independently review the basis for a recommendation affects FDA device status, and accreditation guidance stresses human judgment.

Does a human in the loop make an AI tool safe?

Not by itself. Review has to be informed, timely, and non-perfunctory, and the organization should monitor whether reviewers actually catch errors.

Which AI actions should always need human approval?

Actions that are high-impact or hard to reverse, such as sending clinical messages to patients, changing orders or medications, or submitting claims and authorizations with clinical content.

Related reading

Sources

See Skovos in action. Registry, permission checks, audit trail and a stop control your hospital owns. Talk to us or read Can we stop it?
Governed AI infrastructure for health systems, from first deployment to enterprise scale.
Copyright @2026 Skovos is a trade name of Haver AI Inc. All rights reserved.